Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on AATec Medical GmbH — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

AATec Medical and Northway Biotech Form Partnership to Develop Manufacturing Process for ATL-105 Targeting Lung Disease.

Jul 15, 2025•10 months ago

Contract Type

partnership

BiotechnologyHealth CareTherapeutics

Description

AATec Medical and Northway Biotech have announced a strategic partnership to enhance the manufacturing process for ATL-105, aimed at treating non-cystic fibrosis bronchiectasis. Northway Biotech will utilize its manufacturing expertise to develop a scalable production process for this innovative inhaled therapy.

Company Information

Company

AATec Medical GmbH

About

AATec Medical GmbH is a biotech company focused on developing treatments for respiratory diseases. They specialize in a multi-product platform aimed at addressing various respiratory conditions. Their lead product candidate, ATL-105, represents a novel inhaled therapy. AATec is committed to innovation in the field of lung disease treatment.

Predictive Intelligence
Strategic

ML-powered predictions for AATec Medical GmbH's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months